-
1
T‐Cadherin in Biliary Tract Cancer Stroma, a Potent Pharmacological Target for Biliary Tract Carcinogenesis
Published 2025-04-01Subjects: “…biliary tract cancer…”
Get full text
Article -
2
Prognostic impact of neutrophil-to-lymphocyte ratio (NLR) in patients with unresectable biliary tract cancer treated with gemcitabine, cisplatin, and durvalumab
Published 2025-07-01Subjects: “…Biliary tract cancer…”
Get full text
Article -
3
First-line chemotherapy with selective internal radiation therapy for intrahepatic cholangiocarcinoma: The French ACABi GERCOR PRONOBIL cohort
Published 2025-02-01Subjects: Get full text
Article -
4
Comparison of monotherapy and combination therapy for older patients with advanced biliary tract cancer: a retrospective study
Published 2025-04-01Subjects: Get full text
Article -
5
-
6
Preoperative total bile acid can be used as a prognostic biomarker in patients with operable biliary tract cancers
Published 2025-05-01Subjects: “…Biliary tract cancer…”
Get full text
Article -
7
Gallbladder and biliary tract cancer burdens in China from 1990 to 2021 and projection to 2044: findings from the 2021 Global Burden of Disease study
Published 2025-05-01Subjects: “…gallbladder and biliary tract cancer…”
Get full text
Article -
8
Radical resection of an initially unresectable intrahepatic cholangiocarcinoma after chemotherapy with using gemcitabine, cisplatin, and S-1: report of a case
Published 2019-06-01Subjects: “…Metastatic biliary tract cancer…”
Get full text
Article -
9
Tumor treating fields suppress tumor cell growth and induce immunogenic cell death biomarkers in biliary tract cancer cell lines
Published 2025-08-01Subjects: “…Biliary tract cancer…”
Get full text
Article -
10
Clinical outcomes of transarterial chemoembolization combined with durvalumab for advanced and metastatic biliary tract cancer
Published 2025-12-01Subjects: “…Biliary tract cancer…”
Get full text
Article -
11
The IL-6/JAK/STAT3 Axis in Cholangiocarcinoma and Primary Sclerosing Cholangitis: Unlocking Therapeutic Strategies Through Patient-Derived Organoids
Published 2025-04-01Subjects: “…biliary tract cancer…”
Get full text
Article -
12
Adjuvant Gemcitabine-cisplatin Combination for Biliary Tract Cancer: A Real Life Experience
Published 2025-08-01Subjects: “…biliary tract cancer…”
Get full text
Article -
13
A Case of Advanced Biliary Tract Cancer With EGFR Amplification That Responded to Necitumumab
Published 2024-11-01Subjects: “…biliary tract cancer…”
Get full text
Article -
14
Oral microbiota and biliary tract cancers: unveiling hidden mechanistic links
Published 2025-06-01Subjects: Get full text
Article -
15
Preoperative glasgow prognostic score was an effective prognostic indicator in patients with biliary tract cancer
Published 2025-04-01Subjects: Get full text
Article -
16
Exploring the effects of gut microbiota on cholangiocarcinoma progression by patient-derived organoids
Published 2025-01-01Subjects: Get full text
Article -
17
-
18
Global, regional, and national burden of gallbladder and biliary tract cancer among adults aged 55 years and older, 2010–2021
Published 2025-07-01Subjects: “…gallbladder and biliary tract cancer…”
Get full text
Article -
19
Durvalumab and pembrolizumab in advanced biliary tract cancer: a reconstructed patient-level mimic head-to-head comparative analysis
Published 2024-12-01Subjects: “…biliary tract cancer…”
Get full text
Article -
20
Intrahepatic cholangiocarcinoma trends and treatment lines: real-world evidence from the French National Hospital Discharge database
Published 2025-06-01Subjects: “…biliary tract cancer…”
Get full text
Article